Liver Cancer - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Liver Cancer

- Cancer PHGKB -

What's New

Last Posted: Sep 04, 2019

---

• Challenges of big data integration in the life sciences. 
  Fillinger Sven et al. Analytical and bioanalytical chemistry 2019 Aug
• Taiwan consensus statement on the management of chronic hepatitis B. 
  Chien Rong-Nan et al. Journal of the Formosan Medical Association = Taiwan yi zhi 2019 Jan 118(1 Pt 1) 7-38
• The applications of metabolomics in the molecular diagnostics of cancer. 
  Cheung Pro Kit et al. Expert review of molecular diagnostics 2019 Aug
• A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic. 
  Liu Wei et al. Cancer science 2019 Jul
• The evolving landscape of precision medicine in primary liver cancer. 
  Martin Sean P et al. Hepatic oncology 2019 Jun 6(2) HEP12
• Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features. 
  Wang Clinton J et al. European radiology 2019 May
• The Role of Artificial Intelligence in Interventional Oncology: A Primer. 
  Letzen Brian et al. Journal of vascular and interventional radiology : JVIR 2019 30(1) 38-41.e1
• Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma. 
  Teufel Michael et al. Gastroenterology 2019 156(6) 1731-1741
• Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma? 
  Harding James J et al. Digestive diseases and sciences 2019 Mar
• Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. 
  Yoon Sarah et al. Oncogene 2018 37(32) 4443-4454
• Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie). 
  Huemer Florian et al. BMC cancer 2018 18(1) 11
• Cancer epigenetics in solid organ tumours: A primer for surgical oncologists. 
  Drake Thomas M et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019 Feb
• Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma. 
  Li Binghua et al. Scientific reports 2017 7(1) 5517
• Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma. 
  Yoneda Norihide et al. Japanese journal of radiology 2019 Feb
• Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. 
  Dhanasekaran Renumathy et al. Gastroenterology 2019 156(2) 492-509